Founder in Residence, Non-Transferrable Pesticides

Deep Science Ventures
2 months ago
Applications closed

Related Jobs

View all jobs

Legal Director

Legal Director

Sales Lead

Weekend Microbiologist

SUPPLY CHAIN OPERATIONS MANAGER | LUXURY SKINCARE & BEAUTY TECH

Health And Safety Advisor

Join as a Founder in Residence in Climate

We're on the lookout for entrepreneurial individuals with technical and commercial domain expertise with keen interest in founding, and building a global scale, impact driven, high growth company from ground up.

We are seeking applications from experienced industry, startup and/or new science or engineering based technology development professionals from anywhere in the world to work with us on

You'll work closely with the DSV team, usingour methodology, to spin-out a new company. During the programme, you’ll work on all aspects related to venture creation in this opportunity area, including working out the optimal approach to solve for the desired outcome, building a team and building a viable business case. Once the new venture is incorporated with pre-seed investment from DSV, you and your co-founders will own the majority stake in the business and continue receiving support from the DSV team post-spinout.

The role is full-time, remote initially until venture incorporation and spin-out (circa summer/autumn 2026), location TBD.

About the Opportunity Area

Conventional pesticides—neonicotinoids, pyrethroids, atrazine, organochlorines, organophosphates, and carbamates—are a double-edged sword. They shield crops from pests but wreak havoc beyond their targets. Pollinators like bees and butterflies, vital to 75% of global food crops, are in freefall—some bee populations have declined by over 43% in high-pesticide regions due to lethal and sublethal exposures that impair navigation, immunity, and reproduction. This threatens global food security and biodiversity. Beyond ecosystems, these chemicals cause acute intoxication, cancer, neurodegeneration, infertility, and hormonal disruptions in humans, driven by oxidative stress, DNA damage, and systemic inflammation. The transferability of these pesticides—spreading through soil, water, and trophic chains—amplifies their devastation, making sustainable alternatives non-negotiable.

Non-transferable pesticides have already shown scientific and commercial traction at the proof of concept level. For example, pheromone and other semiochemical approaches have shown success in disrupting pest mating patterns, while insect glues or oils are effective in immobilising pests on contact. However, the ability of non-transferrable pesticides to disrupt the incumbent agrochemical market has thus far been limited. Among the most important constraints in scaling non-transferrable pesticides are high production costs, coverage limitations, efficacy without affecting non-target species, and the risk of evolutionary ‘escape’. For example, Bacillus thuringiensis (‘Bt’) crops such as corn, cotton and soy - arguably the most prominent non-transferrable pesticide technology to date - have demonstrated a decline in efficacy after multiple growth seasons due to evolved resistance.

We imagine a future where pesticides protect crops without decimating pollinators, collapsing food chains, or endangering human health. This is the vision driving our venture creation in this opportunity space: to halt ecological collapse and protect human health by reimagining pest control.

Our Approach

Our preliminary scoping of the area indicates high potential to develop approaches that meet our desired outcome: pest control that is scalable, durable, and effective without off-target effects. Emerging technologies, from RNAi silencing of pest genes through to engineered crop pheromone production, provide a set of promising tools that could provide the foundations for commercially viable propositions. However, each approach presents outstanding constraints that require solving. We believe that advances in diverse sectors, spanning from bioprocessing and genetic engineering through to GIS and precision agriculture tools, mean that it is the ideal time to tackle these barriers and we are looking for a Founder in Residence to take this on.

Requirements

Who We're Looking For

This isn’t just a job—it’s a chance to realise your own vision for venture creation in this space. We need a visionary founder to lead this charge—someone who's a problem-solver with a passion for this opportunity area, comfortable working across multiple scientific disciplines, with a track record that broadly covers most of the following criteria:

  • Deep knowledge of plant-pest interactions or pesticide development (e.g. PhD or equivalent industry R&D know-how focused genomics, molecular biology, entomology, plant pathology, virology and/or bacteriology);
  • In-depth knowledge of state-of-the-art (SOTA) technologies and constraints in pest control, spanning from insecticidal proteins and RNAi through to precision chemical delivery and the implementation of IPM systems;
  • A proven track record of bringing new biotech solutions/products/ventures from concept to market, ideally in agriculture/agrochemical industry;
  • Broad understanding of the agrochemical industry, farmer needs, navigating regulatory frameworks (e.g., EPA, EU pesticide standards) and experience in forging partnerships with agricultural stakeholders is a big plus;
  • Experience in raising funds from early-stage investors/VC is a big plus;
  • A relentless passion to protect pollinators, ecosystems, and human health, with the leadership to drive own vision for venture creation in this space.

Benefits

By joining DSV, you will be part of a team of operators who have founded companies and led the translation of science at some of the most respected universities, charities, funds, and government agencies. Here’s what we offer:

  • Access to optimised, purpose-built, proprietary tools, resources, and processes to help create high-impact ventures from scratch;
  • Opportunity area-specific know-how from our network of Partners and Advisors;
  • Up to £250k in investment to incorporate the new venture and develop early proof-of-concept data;
  • Guaranteed income of £4,166 per month paid as a fixed consultancy fee until the company is launched and the pre-seed investment is secured;
  • Majority equity stake in the new company between  you and your co-founder(s);
  • Continuous post-spinout support, including fundraising, commercial partnerships, recruitment, and team-building;
  • Collaborative support from dozens of Founders currently at DSV across sectors.

About DSV

Deep Science Ventures (DSV) is on a mission to create a future in which both humans and the planet can thrive. We use our unique venture creation process to create, spin-out, and invest in science companies, combining available scientific knowledge and founder-type scientists into high-impact ventures. Operating in four sectors—Pharmaceuticals, Climate, Agriculture, and Computation—we tackle the challenges defining these areas by taking a first principles approach and partnering with leading institutions.

Get the latest insights and jobs direct. Sign up for our newsletter.

By subscribing you agree to our privacy policy and terms of service.

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Negotiating Your Biotech Job Offer: Equity, Bonuses & Perks Explained

How to Secure a Compensation Package That Reflects Your True Value in the UK’s Thriving Life Sciences Sector Introduction Biotechnology is one of the most dynamic and impactful sectors in today’s global economy—particularly in the UK, which boasts a thriving research ecosystem and a burgeoning community of innovative start-ups. From cutting-edge work on gene editing and CAR-T therapy to breakthroughs in diagnostics and personalised medicine, the biotech field promises vast opportunities for mid‑senior professionals to make a meaningful difference. However, with these opportunities comes the need for careful negotiation when evaluating a new role. Biotech companies—whether they’re large pharmaceutical giants or lean start-ups—often structure compensation packages that go far beyond simple salaries. These may include equity grants, performance-based bonuses, and a range of perks designed to attract top talent in a competitive market. Focusing solely on your base salary could mean missing out on substantial long-term rewards or lifestyle benefits. In biotech, your contributions might directly influence life-changing products, high-stakes clinical trials, or novel therapeutic approaches. Hence, your compensation should reflect both the immediate and future value you bring. This article aims to be your comprehensive guide to negotiating a biotech job offer in the UK. We’ll delve into why negotiation goes beyond salary, how equity functions in the biotech context, and how performance bonuses and other perks can amplify the overall value of your compensation. Geared for mid‑senior professionals, this guide offers actionable insights to help you secure a holistic compensation package that aligns with your expertise, future goals, and the impact you will have on advancing life sciences.

Biotech Jobs in the Public Sector: Where to Find Meaningful Careers Across the NHS, Research Councils, and Beyond

Biotechnology has become one of the most vibrant and impactful fields of the 21st century, transforming everything from healthcare and pharmaceuticals to agriculture and environmental conservation. In the UK, the public sector is at the forefront of many biotech initiatives, supported by world-class research institutions, government bodies, and large-scale healthcare networks such as the National Health Service (NHS). For professionals seeking purpose-driven work, biotech jobs in the public sector present a compelling opportunity to blend scientific innovation with a meaningful impact on society. Whether you aspire to develop cutting-edge therapies for chronic diseases, optimise food production in a sustainable way, or champion environmental conservation, the public sector’s broad remit means there are numerous pathways to explore. In this article, we’ll delve into the biotech jobs landscape within the UK public sector—shedding light on why biotechnology is crucial for government bodies, which organisations are leading the charge, and the types of roles available. We’ll also discuss the skills needed to excel in these positions, potential salary ranges, and how to successfully apply. By the end, you’ll have a clearer picture of how you can leverage your biotech expertise to serve the nation through a public sector career.

Contract vs Permanent Biotech Jobs: Which Pays Better in 2025?

In the ever-advancing world of life sciences, biotechnology has emerged as one of the fastest-growing and most impactful sectors in the UK. From gene editing and regenerative medicine to synthetic biology and vaccine development, British biotech organisations are at the forefront of scientific innovation. With this growth comes a high demand for skilled professionals—scientists, data analysts, regulatory affairs specialists, bioprocess engineers, and more—who can help bring cutting-edge treatments and products to market. However, as the biotechnology landscape in the UK continues to expand, so too do the ways in which professionals choose to work. Beyond traditional permanent employment, many biotech specialists are exploring the world of contracting, which can take the form of day‑rate consulting or fixed-term contracts (FTC). Each path promises unique advantages and disadvantages, from pay rates and benefits packages to career development and job security. This article offers a comprehensive guide on contract vs. permanent biotech jobs in 2025. We will explore how the UK biotech sector is shaping up, break down the different types of employment arrangements, and present sample take‑home pay scenarios for each. Our goal is to empower you with the knowledge needed to make an informed decision that aligns with both your financial aspirations and long-term career goals within the vibrant and evolving biotech industry.